CAJ | 학술논문

介入治疗作为一种安全、有效、微创的治疗手段在原发性肝癌的治疗中占有越来越重要的地位。随着肝癌患者生存期的延长，门静脉癌栓患者也增多。近年来医疗技术的不断发展、治疗方法不断更新，在原发性肝癌合并门静脉癌栓的治疗上出现了新的格局。本文就介入治疗原发性肝癌合并门静脉癌栓的现状和进展综述如下。
개입치료작위일충안전、유효、미창적치료수단재원발성간암적치료중점유월래월중요적지위。수착간암환자생존기적연장，문정맥암전환자야증다。근년래의료기술적불단발전、치료방법불단경신，재원발성간암합병문정맥암전적치료상출현료신적격국。본문취개입치료원발성간암합병문정맥암전적현상화진전종술여하。
Intervention as a safe, effective and minimally invasive treatment of hepatocellular carcinoma showed more and more important position. With the survival time of patients with HCC prolonged, the patient with portal vein tumor thrombus is also increasing. With the development of medical technology and treatment, a new situation has appeared in the treatment of primary liver cancer with portal vein tumor thrombus. In this article, some of the intervention technologies are reviewed.